β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99.0% (HPLC) Clofarabine Intermediate High Purity

Kufotokozera Kwachidule:

Dzina: β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate

CAS: 6974-32-9

Maonekedwe: Ufa Woyera Kapena Woyera Wamakristalo

Kuyesa: ≥99.0% (HPLC)

Pakati pa Clofarabine (CAS: 123318-82-1) pochiza Ana omwe ali ndi Acute Lymphoblastic Leukemia (ALL)

Inquiry: alvin@ruifuchem.com

Titumizireni imelo

Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Zamalonda Zogwirizana ndi Clofarabine:
Clofarabine CAS: 123318-82-1
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose CAS: 97614-43-2
β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS: 6974-32-9
1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS: 22224-41-5
2,6-Dichloropurine CAS: 5451-40-1

Chemical Properties:

Dzina la Chemical	β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate
Mawu ofanana ndi mawu	1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-Ribofuranose
Nambala ya CAS	6974-32-9
Nambala ya CAT	RF-PI222
Stock Status	Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula	C28H24O9
Kulemera kwa Maselo	504.49
Mtundu	Ruifu Chemical

Zofotokozera:

Kanthu	Zofotokozera
Maonekedwe	Ufa Woyera kapena Woyera wa Crystalline
Njira Yoyesera / Kusanthula	≥99.0% (HPLC)
Melting Point	126.0 ~ 133.0 ℃
Kutaya pa Kuyanika	≤0.50%
Zotsalira pa Ignition	≤0.50%
Zonse Zonyansa	≤1.00%
Zitsulo Zolemera	≤20ppm
Test Standard	Enterprise Standard
Kugwiritsa ntchito	Pharmaceutical Intermediate wa Clofarabine CAS: 123318-82-1

Phukusi & Kusunga:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, makatoni ng'oma, 25kg / Drum, kapena malinga ndi zofuna za kasitomala.

Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala, chinyezi ndi tizilombo towononga.

Ubwino:

FAQ:

Ntchito:

β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate (CAS 6974-32-9) ndi yapakatikati ya (Clofarabine CAS: 123318-82-1).Clofarabine (CAS: 123318-82-1) ndi mankhwala atsopano a purine nucleoside anticancer omwe amayamba bwino kupangidwa ndi Top10 biopharmaceutical company ya United States-Genzyme Corporation ndi mayina a malonda kukhala "Clofarabine".Pa December 28, 2004 bungwe la US Food and Drug Administration (FDA) linagwiritsa ntchito njira yofulumira kuti ivomereze clofarabine kuti igwiritsidwe ntchito kwa ana omwe ali ndi refractory kapena relapsed acute lymphocytic leukemia (ALL);ali kwambiri efficacy pa matenda a khansa ya m'magazi ndi bwino kulolerana ndipo palibe zosayembekezereka chokhwima zimachitikira.Atha kuperekedwa kudzera m'mitsempha kapena kuperekedwa pakamwa.Mankhwalawa ndi mankhwala oyamba ovomerezeka kuti aperekedwe kuchiza ana a khansa ya m'magazi zaka zoposa khumi.